Cell-Counting Devices Market Size is projected to reach USD 28.45 billion by 2029, with growth at a CAGR of 7.21% over the forecast period 2022-2029

Cell Counting Devices Market is segmented By Product Type (Instruments (Flow Cytometer, Spectrophotometers, Hematology Analyzers, Cell Counters), Media & Consumables, Other Accessories), By End-User (Hospitals, Diagnostic Centers, Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others)

Hyderabad, INDIA

ENTERPRISE, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Cell-Counting Devices Market Size Growth Rate Overview:

  • According to the research report published by DataM Intelligence, the global cell counting devices market size was valued at USD 9.8 billion in 2021; it is projected to reach USD 28.45 billion by 2029, with growth at a CAGR of 7.21% over the forecast period 2022-2029.

  • Easily available products such as spectrophotometers and flow cytometry which are much more convenient, contributed to the growth of the global cell counting devices market, further helping the market growth. Various latest advancements are taking place in the market, with novel product launches. Along with novel product launches and technological advances, the rising demand for cell-counting devices will further support market trends for cell-counting devices through 2029.

  • Cell counting refers to counting cells for several medical applications in hospitals, pharmaceuticals, research organizations and biotechnology research activities. This evaluates the concentration of cells per unit volume in the media. Various treatments are used for counting the number of cells. Cell counting devices provide detailed cell counts that can be done manually or automatically.

Download the Sample Brochure to understand our research methodology, regional analysis, and competitive insights @ https://www.datamintelligence.com/download-sample/cell-counting-devices-market

Cell-Counting Devices Market Drivers Insights:

  • The market has experienced significant growth, ascribed to the growing number of chronic diseases worldwide. According to the National Centre for Health, the second leading mortality cause worldwide is cancer, with over 1,918,030 new cases in 2022.

  • Cancer is in charge of around 609,360 deaths all around the world. The healthcare infrastructure modernization in emerging nations is funded by their governments, which will expand access to healthcare. The need for cell counting devices for vaccine production is anticipated to rise. The global market for cell counting devices has attractive potential due to the rise in the frequency of chronic illnesses in emerging nations.

Cell-Counting Devices Market Restraints:

  • The high cost associated with these cell counting devices, the unavailability of experienced professionals, and the lack of awareness of chronic disorders diagnosis and treatment in developing countries will restrain the market in the forecast period.

  • Various product recalls are also responsible for limiting the market. Many hematology analyzers were recalled by Food and Drugs Administration, including DxH 600, DxH 800 and DxH 900. They were issued a class I recall letter due to platelet count inaccuracy. Therefore, the product recalls of these advanced devices could restrain the expansion of the cell-counting devices market over the estimated year.

Cell-Counting Devices Market Opportunities Insights:

  • Research and medical experts are developing advanced approaches to improve the outcomes of cell counting devices. The major area of research is the latest technological advancements, such as improved imaging analysis and new product launches. Increasing government organization funding in healthcare sectors is boosting the market

  • Growing investments is helping the end-users use novel technologies for cell counting. Infrastructure development and rising investments are expected to provide huge opportunities for the cell counting devices market. This will provide a lucrative opportunity for the growth of the market

COVID-19 Impact Analysis:

  • The health system is under extreme strain due to the COVID-19 pandemic. Compared to COVID-19 mortality avoided among chronic disease patients, the delay in diagnosis and treatment is likely to result in more deaths associated with chronic diseases such as cancer.

  • Prioritizing the treatment of patients with early-stage cancer, increasing the use of cell count devices, and enhancing the number of physicians in the provision of cancer care are a few ways that need to be reorganized in terms of priorities for the provision of care.

Recent Developments in the Industry:

  1. In August 2022, Thermo Fisher Scientific announced the expansion of its cell culture media manufacturing facility in New York to meet the growing demands for cell culture media in vaccine manufacturing.
  2. In June 2022, Merck, a science and technology company, announced its collaboration with Agilent Technologies to advance process analytical technologies (PAT). Process analytical technology is the main enabler for bioprocessing and real-time release and is encouraged by regulatory authorities.

Cell-Counting Devices Market Segmentation:

As per the research analysis, the global cell counting devices market is segmented by product type of cell count devices into instruments, media & consumables and other accessories. By application, the market is further segmented into total blood count, stem-cell research, immunology research, cell-based therapeutics and others. By end-user, the market is segmented into hospitals, diagnostic centers, institute and research centers, pharmaceutical & biotechnology companies and others.

  1. Based on the product type, the instruments segment accounted for the largest market share of around XX% in 2020 and is expected to grow at a CAGR of XX% during the forecast period (2022-2029). Various instruments are used for cell counts, such as a spectrophotometer, cell counter and flow cytometer. Flow cytometry is used for the analysis of single cells. While suspended in a salt-based buffer solution, they flow from single or multiple lasers. Each cell is analyzed for visible light scattering. Various tests are performed using these instruments, such as total blood count, a blood test that evaluates health and detects a broad range of disorders such as infection, leukemia or anemia.

Make an Inquire before Purchasing Full Report @ https://www.datamintelligence.com/enquiry/cell-counting-devices-market

Geographical Classification:

The global cell counting devices market is segmented into major regions: North America, South America, Europe, Asia Pacific, and the Middle East & Africa.

North America Cell-counting devices Market:

  • This large revenue share is mainly due to the rising prevalence of chronic disorders, and the abundance of highly qualified surgeons, among other things. North America is one of the biggest markets for cell counting devices. This region showcases a significant CAGR owing to the rising awareness regarding chronic diseases such as cardiovascular disorders, cancer, COPD and Cystic Fibrosis combined with the increasing demand for these cell counting devices. The significant market share is attributable to the high disease prevention knowledge in the area and the numerous programs initiated to prevent chronic diseases, which have expanded the market for these novels and advanced cell counting devices in this region.

  • Due to the rising awareness regarding chronic diseases, combined with the increasing demand for these cell-counting devices. According to WHO, most cases of infectious disease occur in developing, and underdeveloped regions, mostly in Asia, where healthcare facilities are limited, and awareness about detection and treatment is low. Awareness initiatives taken by governments to educate people about early diagnostic test and treatment has increased in developing nations. By 2029, Japan’s market for cell-counting devices is anticipated to be worth over xx million dollars. Due to numerous aspiring industry players in the area, the China cell-counting devices market is predicted to provide a CAGR of around xx percent, accounting for revenue generation of over USD xx Billion by the conclusion of the projected year.

Cell-Counting Devices Market Competitive Analysis:

However, it is expected to grow rapidly in the next couple of years with intense competition among the players and a rising number of cases. A few key players are already being observed adopting strategies, such as collaboration for developing novel technologically advanced products, which may make the market crowded with new products in the next couple of years.

Cell-Counting Devices Market Major Companies:

Major key companies contributing to the market’s growth include

  • Thermo Fisher Scientific
  • Agilent Technologies Inc
  • Bio-Rad Laboratories, Inc
  • GE Healthcare
  • Becton, Dickinson and Company
  • Merck KGaA
  • Corning Inc
  • Chemometec A/S
  • Tip Biosystems and Paul Marienfield GmbH & Co. KG.

Related Reports:

Cell Line Development Market is Segmented By Types of Cell Lines (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines), By Application (Bioproduction, Tissue Engineering Regenerative Medicines, Toxicity Testing, Research, Drug Discovery), By Source(Mammalian Cell Lines, Non –Mammalian Cell Line), By Product(Reagent and Media, Equipment, Finished Cells, Others), By End-User ( Academics and Research Institutes, Biotech Companies,  Others)

Ophthalmology Amniotic Membrane Market is segmented By Product Type (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane), By End User (Hospital, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research and Academic Institutes)

Body Contouring Devices Market is segmented By Product Type (Invasive (ultrasound-assisted liposuction devices), By Minimally Invasive (Laser-assisted lipolysis devices, Radiofrequency-assisted liposuction devices), By Non-invasive products (Radiofrequency apoplastic devices, High intensity focused ultrasound lipoplasty devices) )

HbA1c Testing Device Market is segmented By Type (Bench-Top, Handheld Device), By Technology (Enzymatic assay, Ion-exchange HPLC, Turbidimetric inhibition immunoassay, Affinity binding chromatography, Others), By End-User (Hospitals, Diagnostic Laboratory, Homecare, Others)

Additional Benefits Post Purchase:

1) Unlimited Analyst support for a period of 1 year.

2) Any query with regard to the scope offered will be addressed within 24- 48 hours.

3) An excel sheet with market numbers will be provided separately.

The Full Report has the following insights:

  • The report comprehensively evaluates the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
  • Visualize the composition of the global cell-counting devices market segmentation by product type, application, end-user, and region, highlighting the key commercial assets and players.
    • By Product Type: Instruments, Media and Consumables and Other Accessories
    • By Application: Total Blood Count, Stem-Cell Research, Immunology Research, Cell-Based Therapeutics and Others
    • By End-user: Hospitals, Diagnostic Centers, Institutes and Research Centers, Pharmaceutical and Biotechnology Companies and Other
    • By Region: North America, South America, Europe, Asia Pacific, and the Middle East & Africa
  • Identify commercial opportunities in the global cell-counting devices market by analyzing trends and co-development deals.
  • The report also covers data insights on various industry forces such as porter's five forces analysis, supply chain analysis, pricing analysis, and regulatory analysis.
  • Excel data sheet with thousands of global cell-counting devices market-level 4/5 segmentation data points.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. 
  • Product mapping in excel for the key product of all major market players
  • The report will provide access to approximately 61 market data tables, 64 figures, and close to 180 pages. 

About Us:

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to clients’ needs in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed and food & beverages, among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across ten major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates ease access and custom personalization to research and markets.


Contact Data